Loading…
Inogen, Inc. is projected to rise to $8.05 by 2027, a +25% move from its current price of $6.45. INGN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $6.34 | $6.46 | $6.58 | +0.08% |
| Aug 5 | $6.29 | $6.46 | $6.63 | +0.16% |
| Aug 6 | $6.26 | $6.47 | $6.68 | +0.24% |
| Aug 7 | $6.23 | $6.47 | $6.72 | +0.33% |
| Aug 8 | $6.21 | $6.48 | $6.75 | +0.41% |
| Aug 9 | $6.19 | $6.48 | $6.78 | +0.49% |
| Aug 10 | $6.17 | $6.49 | $6.81 | +0.57% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.17 | $6.49 | $6.81 | +0.57% |
| Week 2 | $6.08 | $6.52 | $6.99 | +1.14% |
| Week 3 | $6.02 | $6.56 | $7.15 | +1.72% |
| Week 4 | $5.98 | $6.60 | $7.28 | +2.30% |
| Week 5 | $5.94 | $6.64 | $7.41 | +2.88% |
| Week 6 | $5.91 | $6.67 | $7.53 | +3.47% |
| Week 7 | $5.89 | $6.71 | $7.65 | +4.06% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Inogen, Inc. is a medical technology company that develops, manufactures, and markets respiratory health products in the United States and internationally. It provides portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
The company offers Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc.
was incorporated in 2001 and is headquartered in Beverly, Massachusetts.
Inogen trades under the symbol INGN and is currently priced at $6.41 with a market capitalization of $173.55M. It is ranked 3923 by market capitalization.
A major floor 11.3% below — a decisive break under it would weaken the trend.
The nearest floor, 4.7% below — buyers have tended to step in here.
The nearest ceiling, 7.6% above — a clean break opens room to run.
A major ceiling 14.0% above — clearing it would confirm fresh momentum.
Key INGN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of INGN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.41 | Buy | $6.41 | Buy |
| MA 10 | $6.38 | Buy | $6.41 | Buy |
| MA 20 | $6.46 | Sell | $6.44 | Buy |
| MA 50 | $6.46 | Sell | $6.49 | Sell |
| MA 100 | $6.52 | Sell | $6.53 | Sell |
| MA 200 | $6.67 | Sell | $6.73 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.65 | Neutral |
| Stoch RSI (14) | 70.37 | Neutral |
| CCI (20) | -4.23 | Neutral |
| Williams %R (14) | -41.18 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | 0.62 | Buy |
| Bollinger %B (20,2) | 0.49 | Neutral |
| Stochastic %K (14) | 58.82 | Neutral |
| TRIX (15) | -0.08 | Sell |
| Awesome (5,34) | -0.10 | Sell |
| Ultimate (7,14,28) | 46.72 | Neutral |
| Momentum (10) | -0.12 | Sell |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 6.45 | Sell |
| ADX (14) | 6.77 | Neutral |
| ATR (14) | 0.10 | Info |
The 30-day technical picture reads bearish, with RSI14 at 50 and moving averages at SMA50 $6.54 and SMA200 $6.78. The stock faces near-term price friction from support at $5.98 and resistance at $6.94.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.59 | $6.45 | $8.64 | 0% | Neutral | |
| $6.60 | $8.05 | $10.26 | +25% | Bullish | |
| $6.88 | $8.55 | $11.20 | +33% | Bullish | |
| $7.11 | $8.97 | $12.00 | +39% | Bullish | |
| $7.70 | $9.85 | $13.41 | +53% | Bullish | |
| $7.68 | $9.95 | $13.76 | +54% | Bullish | |
| $8.83 | $11.57 | $16.23 | +79% | Bullish | |
| $10.81 | $14.30 | $20.33 | +122% | Bullish | |
| $10.85 | $14.50 | $20.86 | +125% | Bullish | |
| $11.30 | $15.25 | $22.18 | +136% | Bullish | |
| $15.92 | $22.41 | $34.16 | +247% | Bullish | |
| $26.03 | $39.29 | $64.22 | +509% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $5.59 | $6.45 | $7.79 | +0.00% |
| September 2026 | $5.84 | $6.85 | $8.21 | +6.14% |
| October 2026 | $5.90 | $6.95 | $8.39 | +1.45% |
| November 2026 | $5.84 | $6.91 | $8.39 | -0.54% |
| December 2026 | $5.96 | $7.07 | $8.64 | +2.38% |
Click any year to see its month-by-month INGN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, INGN could reach as high as $8.64, with a base case around $6.45 and support toward $5.59 — roughly 0% from $6.45. A consolidation phase looks the most probable path here.
Expect INGN to range from $6.60 to $10.26 through 2027. The $8.05 average target implies a +25% move from current prices. That is up +25% on the projected 2026 average. Momentum favours further upside here.
The INGN price prediction for 2028 points to an average of $8.55 (low $6.88, high $11.20) — a potential gain of +33% on today's $6.45. Buyers look set to stay in control over this stretch.
In 2029, INGN is projected to trade between $7.11 and $12.00, averaging $8.97 — a potential gain of +39% from today's $6.45. That is up +5% on the projected 2028 average. Momentum favours further upside here.
Inogen, Inc.'s 2030 outlook centres on $9.85, within a $7.70 to $13.41 range. That is up +10% on the projected 2029 average. That marks a +53% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, INGN could reach as high as $13.76, with a base case around $9.95 and support toward $7.68 — roughly +54% from $6.45. Momentum favours further upside here.
Expect INGN to range from $8.83 to $16.23 through 2032. The $11.57 average target implies a +79% move from current prices. That is up +16% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The INGN price prediction for 2033 points to an average of $14.30 (low $10.81, high $20.33) — a potential gain of +122% on today's $6.45. Momentum favours further upside here.
In 2034, INGN is projected to trade between $10.85 and $20.86, averaging $14.50 — a potential gain of +125% from today's $6.45. That is up +1% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Inogen, Inc.'s 2035 outlook centres on $15.25, within a $11.30 to $22.18 range. That is up +5% on the projected 2034 average. That marks a +136% change versus current levels. Momentum favours further upside here.
By 2040, INGN could reach as high as $34.16, with a base case around $22.41 and support toward $15.92 — roughly +247% from $6.45. Buyers look set to stay in control over this stretch.
Expect INGN to range from $26.03 to $64.22 through 2050. The $39.29 average target implies a +509% move from current prices. That is up +75% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in INGN today (≈ 155.03876 INGN) could be worth
$6,091.46
+$5,091.46 (+509%) by 2050 · US Dollar
Based on the average projected INGN price of $39.29 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in INGNwould be worth at today's price.
$1,000 invested in INGN on Jul 31, 2025 (≈ 158.478607 INGN) would be worth
$1,022.19
+$22.19 (+2.2%) today · 1.02× · US Dollar
Based on a INGN entry price of $6.31 vs. today's $6.45.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.15 | $1,048.78 | +4.9% |
| 1 month ago | $6.65 | $969.92 | -3.0% |
| 3 months ago | $6.98 | $924.07 | -7.6% |
| 6 months ago | $6 | $1,075 | +7.5% |
| 1 year ago | $6.31 | $1,022.19 | +2.2% |
| All time (5.0y) ago | $82.26 | $78.41 | -92.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our INGN forecast.
Our base-case forecast reaches $13.00 around 2033.
Implied market cap at $13.00: $351.97M
The multi-year forecast shows a pronounced upside from the 2026 baseline. In 2026 the min is $5.59, the avg is $6.41, and the max is $8.82. From 2027 onward the average price climbs to $7.90 (2027), $8.55 (2028), $9.03 (2029), $9.58 (2030), $9.88 (2031), $11.66 (2032), $14.02 (2033), $14.28 (2034), and $15.14 (2035).
The forecast also projects strong long-run returns with an avg of $22.15 in 2040 and $38.87 in 2050, accompanied by ROIs of 245.5% and 506.5% respectively. Overall sentiment is bullish across the horizon.
Tap a question to reveal the answer.
2030 forecast: min $7.38, avg $9.58, max $13.27; ROI 49.4%; sentiment BULLISH.
The forecast shows bullish sentiment from 2027 onward, with rising averages from 2027 ($7.90) through 2050 ($38.87) and ROIs up to 506.5% by 2050, noting these are estimates and not guarantees.
Yes. The 2032 forecast shows avg $11.66 with a min of $8.76 and a max of $16.71, indicating potential to surpass $10 by 2032.
Current price is $6.41 and market cap is $173.55M; the asset is ranked 3923.
Bearish sentiment with RSI 14 at 50, SMA50 at $6.54, SMA200 at $6.78. Support is $5.98 and resistance is $6.94; 30-day range is $5.58 to $7.36.
Inogen, Inc. Community Discussion
0Share your Inogen, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.